Taysha Gene Therapies Inc. (TSHA)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 96
-0.01
-0.1675%
$
1.43B Market Cap
- P/E Ratio
- Div Yield
2.85M Volume
-0.41 Eps
$ 5.97
Previous Close 
Want to track TSHA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Taysha Gene Therapies Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JA Jack Allen Baird | 640,281.32 | $4.35M | $3.96M | -$384,632.63 | -8.85% |
| KT Keith Tapper BMO Capital | 14,781.53 | $101,401.27 | $88,245.71 | -$13,155.56 | -12.97% |
